Imprimis Pharmaceuticals Raises $9.8M In Private Placement

San Diego-based Imprimis Pharmaceuticals announced on Monday that it has raised $9.8M in a private placement. According to Imprimis, the funding came from accredited investors, along with its board of directors and senior management, including its CEO, CFO, and Senior Director of Corporate Development. Imprimis trades on the NASDAQ as IMMY.